Macrae Sandy (CIK 1675687) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-27). Recent activity: Sell SGMO (12,613 shares), Sell SGMO (5,291 shares), Sell SGMO (33,637 shares), Sell SGMO (102,950 shares), Sell SGMO (7,488 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-27 | SANGAMO THERAPEUTICS, INC (SGMO) | PRESIDENT, CEO AND DIRECTOR | Sell | 12,613 | $2,198 |
| 2026-02-26 | SANGAMO THERAPEUTICS, INC (SGMO) | PRESIDENT, CEO AND DIRECTOR | Sell | 5,291 | $2,487 |
| 2026-02-26 | SANGAMO THERAPEUTICS, INC (SGMO) | PRESIDENT, CEO AND DIRECTOR | Sell | 33,637 | $15,809 |
| 2026-01-26 | SANGAMO THERAPEUTICS, INC (SGMO) | PRESIDENT, CEO AND DIRECTOR | Sell | 102,950 | $41,180 |
| 2025-11-26 | SANGAMO THERAPEUTICS, INC (SGMO) | PRESIDENT, CEO AND DIRECTOR | Sell | 7,488 | $3,145 |
| 2025-10-24 | SANGAMO THERAPEUTICS, INC (SGMO) | PRESIDENT, CEO AND DIRECTOR | Sell | 126,950 | $83,787 |
| 2025-08-26 | SANGAMO THERAPEUTICS, INC (SGMO) | PRESIDENT, CEO AND DIRECTOR | Sell | 7,488 | $4,418 |
| 2025-07-24 | SANGAMO THERAPEUTICS, INC (SGMO) | PRESIDENT, CEO AND DIRECTOR | Sell | 126,950 | $60,936 |
| 2025-05-28 | SANGAMO THERAPEUTICS, INC (SGMO) | PRESIDENT, CEO AND DIRECTOR | Sell | 7,488 | $3,519 |
| 2025-04-24 | SANGAMO THERAPEUTICS, INC (SGMO) | PRESIDENT, CEO AND DIRECTOR | Sell | 126,950 | $99,021 |
Source: SEC Form 4 filings · as of 2026-05-27